Inflation Causes Fear Of Vietnam Drug Shortage
This article was originally published in PharmAsia News
Executive Summary
Vietnam faces a possible shortage of drugs because of recent inflation-driven price increases, according to pharmaceuticals and hospitals represented at a conference. In Da Nang, the retail price of drugs has increased by as much as 30 percent during the past few months even though distributors are honoring contracts signed when prices were lower. Citing the increase, one hospital head said there was a chance hospitals in Vietnam soon would see a shortage of drugs. The head of the Ministry of Health's drug administration said the government would raise caps on drug prices the rest of this year, but only in sync with the consumer price index. (Click here for more
You may also be interested in...
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.
Report Finds Digital Diabetes Tools Deliver No ‘Meaningful Clinical Benefits'
A new report from health economics group the Peterson Health Technology Institute found that apps to help patients manage their blood sugar levels delivered few of the promised benefits. However, a digital therapeutics industry association says PHTI’s research cast too narrow a net.
Merck’s Winrevair Well Positioned To Benefit From Medicare Part D Redesign
Significant cost sharing reductions under the redesign will enhance uptake of the pulmonary arterial hypertension drug. The trade-off is a 20% mandatory price discount in the catastrophic phase.